VIRACTA THERAPEUTICS INC (VIRX)

US92765F1084 - Common Stock

0.21  0 (-1.87%)

After market: 0.2274 +0.02 (+8.29%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
240K
-64.18%
2.07M
762.50%
120K
-94.20%

-100.00%
15.514M63.113M
306.81%
147.3M
133.39%
196.36M
33.31%
238.25M
21.33%
EBITDA
YoY % growth
-25.7M
25.31%
N/A
5.08%
N/AN/AN/A
-96.64%
N/A
0.36%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-25.71M
25.31%
-23.29M
9.41%
-22.3M
4.25%
-123.372M
-15.70%
-54.921M
-96.09%
-51.4M
-0.20%
-44.383M
12.45%
-43.378M
2.26%
-35.324M
18.57%
-44.554M
-26.13%
-15.536M
65.13%
57.701M
471.41%
97.158M
68.38%
131.55M
35.40%
Operating Margin
-10,712.50%-1,125.12%-18,583.33%N/AN/AN/AN/AN/AN/A-287.18%-24.62%39.17%49.48%55.22%
EPS
YoY % growth
-26.25
50.66%
-10.50
60.00%
-5.60
46.67%
-3.79
89.11%
-1.43
-113.11%
-1.30
-1.54%
-0.82
38.18%
-0.37
55.00%
-0.41
-11.11%
-0.33
20.00%
-0.08
75.00%
0.42
612.50%
0.66
58.54%
0.86
29.23%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth
-0.20
43.17%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/A
EBIT
Q2Q % growth
-10.035M
26.00%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.27
18.18%
-0.25-0.02-8.04%
Q2 2024
Q2Q % growth
-0.25
21.88%
-0.380.1333.76%
Q1 2024
Q2Q % growth
-0.23
28.13%
-0.360.1336.03%
Q4 2023
Q2Q % growth
-0.35
-29.63%
-0.32-0.03-10.69%
Q3 2023
Q2Q % growth
-0.33
29.79%
-0.31-0.02-6.08%
Q2 2023
Q2Q % growth
-0.32
-14.29%
-0.30-0.02-8.18%
Q1 2023
Q2Q % growth
-0.32
-14.29%
-0.320.00-0.39%
Q4 2022
Q2Q % growth
-0.27
12.90%
-0.390.1231.25%
Q3 2022
Q2Q % growth
-0.47
-17.50%
-0.31-0.16-51.08%
Q2 2022
Q2Q % growth
-0.28
-12.00%
-0.300.027.73%
Q1 2022
Q2Q % growth
-0.28
-180.00%
-0.320.0412.85%
Q4 2021
Q2Q % growth
-0.31
57.82%
-0.440.1330.13%
Q3 2021
Q2Q % growth
-0.40
60.59%
-0.32-0.08-26.50%
Q2 2021
Q2Q % growth
-0.25
88.10%
-0.24-0.01-3.56%
Q1 2021
Q2Q % growth
0.35
120.00%
-0.210.56263.40%
Q4 2020
Q2Q % growth
-0.74
58.00%
-0.980.2525.13%
Q3 2020
Q2Q % growth
-1.02
51.67%
-1.200.1915.55%
Q2 2020
Q2Q % growth
-2.10
33.33%
-1.98-0.12-5.99%
Q1 2020
Q2Q % growth
-1.75
50.00%
-2.490.7429.72%
Q4 2019
Q2Q % growth
-1.75
68.75%
-2.630.8833.53%
Q3 2019
Q2Q % growth
-2.10
66.67%
-3.030.9330.80%
Q2 2019
Q2Q % growth
-3.15
55.00%
-3.540.3911.10%
Q1 2019
Q2Q % growth
-3.50
52.38%
-6.192.6943.41%
Q4 2018
Q2Q % growth
-5.60 -7.551.9525.83%
Q3 2018
Q2Q % growth
-6.30 -7.851.5519.79%
Q2 2018
Q2Q % growth
-7.00 -8.571.5718.30%
Q1 2018
Q2Q % growth
-7.35 -9.552.2023.03%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2021
Q2Q % growth

-100.00%
4.59M-4.59M-100.00%
Q4 2020
Q2Q % growth

-100.00%
%
Q2 2020
Q2Q % growth
191.25K-191.25K-100.00%
Q1 2020
Q2Q % growth
120K 191.25K-71.25K-37.25%
Q4 2019
Q2Q % growth
2.07M 318.75K1.751M549.41%
Q3 2019
Q2Q % growth
204K-204K-100.00%
Q2 2019
Q2Q % growth
153K-153K-100.00%
Q1 2019
Q2Q % growth

-100.00%
459K-459K-100.00%
Q4 2018
Q2Q % growth
270.3K-270.3K-100.00%
Q3 2018
Q2Q % growth
204K-204K-100.00%
Q2 2018
Q2Q % growth
288.997K-288.997K-100.00%
Q1 2018
Q2Q % growth
240K 204K36K17.65%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 34.27% 8.05% 8.05%
RevenueN/A N/A N/A N/A